This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2026
Title: Ayah Abdeldayem: Innovator in Pharmaceutical Chemistry
Introduction
Ayah Abdeldayem is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzenesulfonamide derivatives.
Latest Patents
Abdeldayem holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes benzenesulfonamide derivatives characterized by a specific formula, along with pharmaceutical compositions that incorporate these compounds. The methods described in the patent focus on using these compounds to disrupt proteins and polypeptides, which can be crucial for treating diseases linked to protein or polypeptide dysfunction. The compounds feature fluorinated benzene sulfonamide structures, showcasing Abdeldayem's expertise in developing novel therapeutic agents.
Career Highlights
Throughout his career, Ayah Abdeldayem has worked with various companies, including 2692372 Ontario, Inc. and Dunad Therapeutics Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical research and development.
Collaborations
Abdeldayem has collaborated with professionals such as Aaron D. Cabral and Sana Rasheed, who is a woman. These collaborations have likely enriched his research and development efforts, fostering a dynamic exchange of ideas and expertise.
Conclusion
Ayah Abdeldayem is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative approach to developing benzenesulfonamide derivatives highlights his commitment to advancing medical science.